When longevity influencer Bryan Johnson publicizes his use of high-dose psychedelics, he creates a risky 'survivorship bias.' His massive audience may only see his curated, successful experience and attempt to replicate it without his resources or preparation, ignoring the unseen negative outcomes others have faced with similar protocols.

Amid dozens of successful studies, one of the only psychedelic trials to report a negative result provides a compelling control case. The trial administered psychedelics to patients inside a claustrophobic, noisy MRI scanner with no psychological support, suggesting a hostile environment can completely negate the drug's therapeutic potential.

Psychology is moving away from a firm distinction between personality and mental health. A persistent mental health issue, by definition, is a stable pattern of experience and behavior, which fits the scientific definition of a personality trait. The two concepts are fundamentally intertwined.

Using substances for transcendental experiences without integrating those states into daily life is a form of escapism. If the experience doesn't change how you show up in your relationships and responsibilities, you are merely treating a symptom, not the cause, which often leads to an increasing dependency on the substance.

Psychedelics disrupt normal brain patterns, which can be powerful for breaking out of neurobiological ruts in middle age. However, using them during the already chaotic and plastic period of brain development in one's 20s may be unnecessarily risky before the brain is 'fully cooked.'

To quickly distinguish a competent psychedelic practitioner from a charlatan, ask about their protocol for adverse events or 'freak outs.' An experienced, honest guide will have a detailed answer, while someone who is inexperienced or dishonest will claim they never happen.

Psychedelics don't erase traumatic memories. Their therapeutic power comes from inducing a massive perspective shift, allowing the individual to view the same event through a completely new and less threatening lens. This insight suggests most psychological suffering is a perspective problem.

A major risk in psychedelic therapy is that vulnerable patients may generate what feel like 'recovered memories' of trauma. Good clinical practice requires therapists to remain neutral on the memory's truthfulness, instead working with its symbolic or emotional content to avoid implanting false and damaging beliefs.

Current mental health drugs force a choice: slow-acting daily pills or rapid-acting treatments like Spravato that require frequent, life-disrupting clinic visits. Psychedelic therapies offer a new paradigm by combining rapid onset of efficacy with durability lasting weeks or months from a single dose.